Encompass Health (Encompass Health) COGS-to-Revenue : 0.05 (As of Dec. 2023)

View and export this data going back to 1989. Start your Free Trial

What is Encompass Health COGS-to-Revenue?

Encompass Health's Cost of Goods Sold for the three months ended in Dec. 2023 was $59 Mil. Its Revenue for the three months ended in Dec. 2023 was $1,247 Mil.

Encompass Health's COGS to Revenue for the three months ended in Dec. 2023 was 0.05.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Encompass Health's Gross Margin % for the three months ended in Dec. 2023 was 95.30%.

Encompass Health COGS-to-Revenue Historical Data

The historical data trend for Encompass Health's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Encompass Health COGS-to-Revenue Chart

Encompass Health Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

COGS-to-Revenue

Get a 7-Day Free Trial

0.04

0.05

Encompass Health Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
COGS-to-Revenue	Get a 7-Day Free Trial															0.05	0.05	0.04	0.04	0.05

Encompass Health COGS-to-Revenue Calculation

Encompass Health's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	218.3	/	4801.2
	=	0.05

Encompass Health's COGS to Revenue for the quarter that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	58.6	/	1246.8
	=	0.05

Encompass Health (NYSE:EHC) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Encompass Health's Gross Margin % for the three months ended in Dec. 2023 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	58.6 / 1246.8
	=	95.30 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Encompass Health COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Encompass Health's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Encompass Health (Encompass Health) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Encompass Health Corp (NYSE:EHC) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

HSOA:Germany

Address

9001 Liberty Parkway, Birmingham, AL, USA, 35242

Website

https://www.encompasshealth.com

Encompass Health Corp provides post-acute healthcare services in the United States through a network of inpatient rehabilitation hospitals. Inpatient rehabilitation contributes the majority of the firm's revenue and provides specialized rehabilitative treatment through a network of inpatient hospitals. These hospitals are concentrated in the eastern half of the United States and Texas.

Executives

Douglas E Coltharp	officer: EVP, Chief Financial Officer	C/O UNDER ARMOUR, INC., 1020 HULL STREET, BALTIMORE MD 21230
Elissa Joy Charbonneau	officer: Chief Medical Officer	24 HAWTHORNE CIRCLE, YARMOUTH ME 04096
Mark J Tarr	officer: Executive VP Operations	C/O ENCOMPASS HEALTH CORPORATION, 9001 LIBERTY PARKWAY, BIRMINGHAM AL 35242
Greg D Carmichael	director
Kevin J. O'connor	director	13995 PASTEUR BOULEVARD, PALM BEACH GARDENS FL 33418
Terrance Williams	director	7184 BIDDICK, NEW ALBANY OH 43054
Christopher R Reidy	director	ONE ADP BLVD, ROSELAND NJ 07068
Andrew L Price	officer: Interim Chief Accting Officer	3660 GRANDVIEW PARKWAY, SUITE 200, BIRMINGHAM AL 35243
Barbara Ann Jacobsmeyer	officer: EVP, Operations	2122 ACTON PARK WAY, BIRMINGHAM AL 35243
Donald L Correll	director	C/O INTERCHANGE FINANCIAL SERVICES CORP, PARK 80 W PLAZA TWO, SADDLE BROOK NJ 07663
Anthony April Kaye Bullock	officer: CEO and President, Encompass	3606 PRINCETON AVENUE, DALLAS TX 75205
Higdon Leo I Jr	director	1700 LINCOLN STREET, 28TH FLOOR, DENVER CO 80203
Patricia Anne Maryland	director	7342 HORIZON DRIVE, WEST PALM BEACH FL 33412
Yvonne M Curl	director	C/O ENHABIT, INC., 6688 N. CENTRAL EXPRESSWAY, SUITE 1300, DALLAS TX 75206
Cheryl B. Levy	officer: Chief Human Resources Officer	3137 BROOK HIGHLAND DRIVE, BIRMINGHAM AL 35242